RBD5044 for mixed high cholesterol and triglycerides
Part of Hormones & metabolism clinical trials.
This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- Your fasting triglyceride level is between 150 and 499 mg/dL.
- Your non-HDL cholesterol is 100 mg/dL or higher, or your LDL cholesterol is 70 mg/dL or higher, despite being on a stable statin (with or without ezetimibe) for at least 4 weeks.
- Your body mass index (BMI) is between 18 and 40.
- You do not have uncontrolled high blood pressure, serious mental illness, or active hepatitis B, C, or HIV.
- Your liver and kidney function tests are within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This trial tests a new medicine called EDP167 for adults with mixed dyslipidemia, a condition of high cholesterol and triglycerides. It aims to see if the drug lowers lipids more than current treatments and how safe it is.
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
Hear when a new Dyslipidemias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.